Stock Detail
$TEM
Healthcare · 12 tracked mentions in the last 90 days across 8 creators.
Valuation and creator stance reflect the last 90 days. The mention feed below shows the latest tracked mentions across all history.
TEM leans undervalued across 4 creators and 5 classified valuation claims, with 2 direct claims carrying most of the signal.
Creator Evidence
Why creators say this
Explicit claim • strong conviction • basis: explicit term
Now trading for a P/E ratio of just 12 times that $3.36 profits expected this year, that is deep value territory and ready to buy.
Implied claim • moderate conviction • basis: drawdown discount
Tempus AI right now is down 50% from all-time highs while the business and demand grew
Explicit claim • weak conviction • basis: multiple relative
but valuation is already rich. The trailing price to sales multiple is about 9.8 price to book is around $ 31.6 and operating cash flow was still negative $80.8 8 million for the first half.
Contextual claim • moderate conviction • basis: fair value gap
So to catch them at around $40 to $45, I would say that is the attractive price point because then on paper, I would say they're undervalued.
Mention History
Latest mentions across all history
Feed